Table_1_Possible Benefits of a Low Protein Diet in Older Patients With CKD at Risk of Malnutrition: A Pilot Randomized Controlled Trial.DOC by Lara Caldiroli (8655168)

“…</p>Clinical Trial Registration<p>https://clinicaltrials.gov/ct2/show/NCT05015647, identifier: NCT05015647.</p>…”

Data_Sheet_1_Possible Benefits of a Low Protein Diet in Older Patients With CKD at Risk of Malnutrition: A Pilot Randomized Controlled Trial.docx by Lara Caldiroli (8655168)

“…</p>Clinical Trial Registration<p>https://clinicaltrials.gov/ct2/show/NCT05015647, identifier: NCT05015647.</p>…”

Image_1_Three-Month Follow-Up of Heterologous vs. Homologous Third SARS-CoV-2 Vaccination in Kidney Transplant Recipients: Secondary Analysis of a Randomized Controlled Trial.pdf by figshare admin frontiersin (4545187)

“…In line, antibody levels in seroconverted patients further increased from month 1 to month 3 in the vector group while remaining unchanged in the mRNA group (median increase: mRNA = 1.35 U/ml and vector = 27.6 U/ml, p = 0.004). …”

Data_Sheet_1_Possible Benefits of a Low Protein Diet in Older Patients With CKD at Risk of Malnutrition: A Pilot Randomized Controlled Trial.docx by Lara Caldiroli (8655168)

“…</p>Clinical Trial Registration<p>https://clinicaltrials.gov/ct2/show/NCT05015647, identifier: NCT05015647.</p>…”

Table 1_Iliac Calcium Score thresholds predict cardiovascular and limb-related outcomes in TASC D aortoiliac disease.docx by António Pereira-Neves (22262164)

“…This study evaluated the prognostic value of a CT-based Iliac Calcium Score (ICS) in predicting major adverse limb events (MALE), cardiovascular events (MACE), and all-cause mortality in patients with severe aortoiliac disease.…”

Image 1_Application and validation of the machine learning-based multimodal radiomics model for preoperative prediction of lateral lymph node metastasis in papillary thyroid carcin... by Jia-Wei Feng (10754067)

“…Background<p>Papillary thyroid carcinoma (PTC) frequently develops lateral lymph node metastasis (LLNM) in 12.6%-32.8% of patients, increasing recurrence risk and mortality. Current diagnostic methods show significant limitations, with occult LLNM rates of 41.0%-51.7% requiring secondary surgeries. …”

Image_1_Tau PET With 18F-THK-5351 Taiwan Patients With Familial Alzheimer's Disease With the APP p.D678H Mutation.tif by Chin-Chang Huang (188904)

“…</p><p>Conclusion: Tau deposition was increased in the patients with fMCI compared to the HCs. …”

Direct Anatomic Reimplantation of Malignant Right Coronary Artery Without Aortotomy: A Two Patient Case Report by Douglas O’Connell (11613710)

“…Varying partial intramural segments were also noted on CT for both patients. With the increased risk of further ischemia and shared decision-making, the patients opted to undergo open-heart surgery for reimplantation of the RCA to a trouble-free origin at the right (posterior) aortic sinus.…”

Data_Sheet_1_Relationships between irregular pulsation and variations in morphological characteristics during the cardiac cycle in unruptured intracranial aneurysms by 4D-CTA.docx by Shiyao Chen (8562999)

“…The UIAs with irregular pulsation exhibited greater changes in morphological characteristics. As aneurysm size increased, the absolute change in aneurysm volume increased (p = 0.035), but the relative rates of change in aneurysm size (p = 0.013), height (p = 0.014), width (p = 0.008), height-to-width ratio (p = 0.009), dome-to-neck ratio (p = 0.019) and bottleneck factor (p = 0.012) decreased.…”

Patterns of renal and splanchnic sympathetic vasomotor activity in an animal model of survival to experimental sepsis by M.I.O. Milanez (12728745)

Table_2_Clinical Efficacy, Safety and Tolerability of a New Subcutaneous Immunoglobulin 16.5% (Octanorm [Cutaquig®]) in the Treatment of Patients With Primary Immunodeficiencies.do... by Roger H. Kobayashi (6291587)

“…<p>Introduction: Subcutaneously administered immunoglobulin (SCIG) is increasingly used to treat patients with primary immunodeficiencies (PIDs). …”

Table_1_Clinical Efficacy, Safety and Tolerability of a New Subcutaneous Immunoglobulin 16.5% (Octanorm [Cutaquig®]) in the Treatment of Patients With Primary Immunodeficiencies.do... by Roger H. Kobayashi (6291587)

“…<p>Introduction: Subcutaneously administered immunoglobulin (SCIG) is increasingly used to treat patients with primary immunodeficiencies (PIDs). …”

Intervention fidelity in the inSCALE arms. by Karin Källander (214970)

“…</p><p>Trial Registration:ClinicalTrials.gov (<a href="https://clinicaltrials.gov/ct2/show/NCT01972321" target="_blank">NCT01972321</a>).…”

Presentation_1_SARS-CoV-2-mRNA Booster Vaccination Reverses Non-Responsiveness and Early Antibody Waning in Immunocompromised Patients – A Phase Four Study Comparing Immune Respons... by Angelika Wagner (316853)

“…</p>Trial registration<p>EudraCT Number: 2021-000291-11</p>…”

S4 File. Stata data set - by Amanuel Yoseph (8962478)

“…<div><p>Introduction</p><p>Increasing knowledge of obstetric danger signs (ODS) and encouraging birth preparedness and complication readiness (BPCR) practices are strategies to increase skilled maternal health service utilization in low-income countries. …”

Intervention package description. by Karin Källander (214970)

“…</p><p>Trial Registration:ClinicalTrials.gov (<a href="https://clinicaltrials.gov/ct2/show/NCT01972321" target="_blank">NCT01972321</a>).…”

The Discovery of C7-Substituted Norbornyl Bisamides as RXFP1 Small Molecule Agonists by Shun Su (1341414)

“…Compound <b>39</b> induced a dose-dependent heart rate increase in isoflurane-anesthetized naïve rats, which is consistent with the hemodynamic profile of relaxin in rat. …”

Assessment of remnant liver function and volume after selective ligation of portal vein and hepatic artery in a rat model by Thiago Boechat de Abreu (8303190)

“…Results: The largest regeneration rate and increase of weight in the hypertrophied lobe was detected in group IV, the first with an average of 3.99 (p=0.006) and the last varying from 6.10g to 9.64g (p=0.01). …”

Image_1_Systematic Review and Pharmacological Considerations for Chloroquine and Its Analogs in the Treatment for COVID-19.pdf by Hongwei Peng (5463218)

“…We have listed all the clinical trials and made a meta-analysis of published data of hydroxychloroquine (HCQ). HCQ could increase the CT improvement and adverse reactions (ADRs) significantly though there was considerable heterogeneity among current researches. …”

Data_Sheet_1_Feasibility, usability, and acceptance of “Brain-IT”—A newly developed exergame-based training concept for the secondary prevention of mild neurocognitive disorder: a... by Patrick Manser (11203791)

“…The intervention group had an attrition rate of 20% and mean adherence and compliance rates of 85.0 and 84.1%, respectively. …”